Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2021  |  Volume : 19  |  Issue : 3  |  Page : 144-150

Study of exposure to dexamethasone among children with acute lymphoblastic leukemia and effect on intellectual function – A pilot study


1 Department of Pediatrics, MNDF Senahiya Militrary Hospital, Moonlight Hingun, Malé, Maldives
2 Department of Paediatrics, 166 Military Hospital, Jammu, Jammu and Kashmir, India
3 Department of Psychiatry, 166 Military Hospital, Jammu, Jammu and Kashmir, India
4 Department of Anaesthesiology and Critical Care, Level III Hospital, Goma, Democratic Republic of the Congo
5 Department of Radiodiagnosis, Ojas Hospital, Panchkula, Haryana, India
6 Department of Obstetrics and Gynaecology, Level III Hospital, Goma, Democratic Republic of the Congo

Correspondence Address:
Harpreet Singh Dhillon
Department of Psychiatry, 166 Military Hospital, Jammu, Jammu and Kashmir
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/cmi.cmi_19_21

Rights and Permissions

Background: There has been significant increase in the remission rates for childhood acute lymphoblastic leukemia (ALL) with addition of corticosteroids to chemotherapy regimens. However, with increase in survivors, there has been increase in the incidence of neurocognitive dysfunction as a 'long term sequelae. The present study was undertaken with the aim to study the effect of a chemotherapy regimen with dexamethasone on intellectual abilities in children with ALL. Methodology: This was a prospective, observational, and descriptive study conducted at a tertiary care hospital over a period of 18 months. Sixty children aged between 6 and 12 years diagnosed with B cell ALL and belonging to the standard risk ALL group on treatment protocol Pediatric Berlin-Frankfurt-Munster (1–10 years) (standard risk), initiated and maintained on oral dexamethasone as part of their chemotherapy regimen were recruited. All the patients were followed up for 6 months and assessed for intellectual ability using Raven's standard progressive matrices (SPM), which was carried out before starting oral dexamethasone, at 3 months and after 6 months of starting oral dexamethasone. Results: The scores obtained at three intervals were compared by one-way repeated analysis of variance and the results showed a significant increase in raw scores of SPM. The difference between the mean scores at the three specified intervals was statistically significant (P < 0.001). The overall maximum improvement (mean raw scores of 5.5) was seen over 6 months period in older age group (12 years). Gender-wise comparison of performance revealed an overall better scores in males, though the differences were not significant. Conclusion: The current study revealed a significant increase in raw scores of SPM in children with standard risk B cell ALL undergoing chemotherapy along with dexamethasone. However, randomized control studies with larger sample size followed up longitudinally for a longer period of time are needed for specific recommendations of using dexamethasone over other corticosteroids.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed728    
    Printed20    
    Emailed0    
    PDF Downloaded108    
    Comments [Add]    

Recommend this journal